questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Terpènes
Monoterpènes
Monoterpènes : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Monoterpènes : Questions médicales les plus fréquentes",
"headline": "Monoterpènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Monoterpènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-08",
"dateModified": "2025-05-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Monoterpènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Terpènes",
"url": "https://questionsmedicales.fr/mesh/D013729",
"about": {
"@type": "MedicalCondition",
"name": "Terpènes",
"code": {
"@type": "MedicalCode",
"code": "D013729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Monoterpènes acycliques",
"alternateName": "Acyclic Monoterpenes",
"url": "https://questionsmedicales.fr/mesh/D000080462",
"about": {
"@type": "MedicalCondition",
"name": "Monoterpènes acycliques",
"code": {
"@type": "MedicalCode",
"code": "D000080462",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Monoterpènes bicycliques",
"alternateName": "Bicyclic Monoterpenes",
"url": "https://questionsmedicales.fr/mesh/D000081008",
"about": {
"@type": "MedicalCondition",
"name": "Monoterpènes bicycliques",
"code": {
"@type": "MedicalCode",
"code": "D000081008",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.141"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cyclohexane monoterpenes",
"alternateName": "Cyclohexane Monoterpenes",
"url": "https://questionsmedicales.fr/mesh/D000081005",
"about": {
"@type": "MedicalCondition",
"name": "Cyclohexane monoterpenes",
"code": {
"@type": "MedicalCode",
"code": "D000081005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.157"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Limonène",
"alternateName": "Limonene",
"url": "https://questionsmedicales.fr/mesh/D000077222",
"about": {
"@type": "MedicalCondition",
"name": "Limonène",
"code": {
"@type": "MedicalCode",
"code": "D000077222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.157.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cyclopentane monoterpenes",
"alternateName": "Cyclopentane Monoterpenes",
"url": "https://questionsmedicales.fr/mesh/D000081004",
"about": {
"@type": "MedicalCondition",
"name": "Cyclopentane monoterpenes",
"code": {
"@type": "MedicalCode",
"code": "D000081004",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pyréthrines",
"alternateName": "Pyrethrins",
"url": "https://questionsmedicales.fr/mesh/D011722",
"about": {
"@type": "MedicalCondition",
"name": "Pyréthrines",
"code": {
"@type": "MedicalCode",
"code": "D011722",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alléthrine",
"alternateName": "Allethrins",
"url": "https://questionsmedicales.fr/mesh/D000487",
"about": {
"@type": "MedicalCondition",
"name": "Alléthrine",
"code": {
"@type": "MedicalCode",
"code": "D000487",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188.750.272"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perméthrine",
"alternateName": "Permethrin",
"url": "https://questionsmedicales.fr/mesh/D026023",
"about": {
"@type": "MedicalCondition",
"name": "Perméthrine",
"code": {
"@type": "MedicalCode",
"code": "D026023",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188.750.636"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Alléthrine",
"alternateName": "Allethrins",
"url": "https://questionsmedicales.fr/mesh/D000487",
"about": {
"@type": "MedicalCondition",
"name": "Alléthrine",
"code": {
"@type": "MedicalCode",
"code": "D000487",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188.750.272"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perméthrine",
"alternateName": "Permethrin",
"url": "https://questionsmedicales.fr/mesh/D026023",
"about": {
"@type": "MedicalCondition",
"name": "Perméthrine",
"code": {
"@type": "MedicalCode",
"code": "D026023",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188.750.636"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cymènes",
"alternateName": "Cymenes",
"url": "https://questionsmedicales.fr/mesh/D000081007",
"about": {
"@type": "MedicalCondition",
"name": "Cymènes",
"code": {
"@type": "MedicalCode",
"code": "D000081007",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.219"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thymol",
"alternateName": "Thymol",
"url": "https://questionsmedicales.fr/mesh/D013943",
"about": {
"@type": "MedicalCondition",
"name": "Thymol",
"code": {
"@type": "MedicalCode",
"code": "D013943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Monoterpènes",
"alternateName": "Monoterpenes",
"code": {
"@type": "MedicalCode",
"code": "D039821",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Julián E Sánchez-Velandia",
"url": "https://questionsmedicales.fr/author/Juli%C3%A1n%20E%20S%C3%A1nchez-Velandia",
"affiliation": {
"@type": "Organization",
"name": "Engineering Faculty, Chemical Engineering Department, Environmental Catalysis Research Group, Universidad de Antioquia UdeA, Calle 70 No. 52-21, 1226 Medellín, Colombia."
}
},
{
"@type": "Person",
"name": "Sol M Mejía",
"url": "https://questionsmedicales.fr/author/Sol%20M%20Mej%C3%ADa",
"affiliation": {
"@type": "Organization",
"name": "Facultad de Ciencias, Departamento de Química, Grupo de Investigación Fitoquímica Universidad Javeriana (GIFUJ)-Línea de investigación en Química Computacional, Pontificia Universidad Javeriana, 11001000 Bogotá, Colombia."
}
},
{
"@type": "Person",
"name": "Meng-Yuan Jiang",
"url": "https://questionsmedicales.fr/author/Meng-Yuan%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, China."
}
},
{
"@type": "Person",
"name": "Xiao-Yun Pu",
"url": "https://questionsmedicales.fr/author/Xiao-Yun%20Pu",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, China."
}
},
{
"@type": "Person",
"name": "Xiang-Zhong Huang",
"url": "https://questionsmedicales.fr/author/Xiang-Zhong%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission & Ministry of Education, Yunnan Minzu University, Kunming, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36251860",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13506129.2022.2131384"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39346594",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1385089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reward network dysfunction is associated with cognitive impairment after stroke.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37307650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2023.103446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of cognitive dysfunction one-year post COVID-19.",
"datePublished": "2023-01-05",
"url": "https://questionsmedicales.fr/article/36603126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/neu0000876"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36729842",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RHU.0000000000001888"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Terpènes",
"item": "https://questionsmedicales.fr/mesh/D013729"
},
{
"@type": "ListItem",
"position": 5,
"name": "Monoterpènes",
"item": "https://questionsmedicales.fr/mesh/D039821"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Monoterpènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Monoterpènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Monoterpènes",
"description": "Comment identifier les monoterpènes dans un échantillon ?\nQuels tests sont utilisés pour analyser les monoterpènes ?\nLes monoterpènes peuvent-ils être détectés dans le sang ?\nQuels symptômes indiquent une exposition aux monoterpènes ?\nY a-t-il des biomarqueurs pour les monoterpènes ?",
"url": "https://questionsmedicales.fr/mesh/D039821?mesh_terms=Cognitive+Dysfunction&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Monoterpènes",
"description": "Quels sont les effets des monoterpènes sur la santé ?\nLes monoterpènes causent-ils des allergies ?\nQuels symptômes respiratoires peuvent survenir ?\nLes monoterpènes affectent-ils le système nerveux ?\nPeuvent-ils provoquer des maux de tête ?",
"url": "https://questionsmedicales.fr/mesh/D039821?mesh_terms=Cognitive+Dysfunction&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Monoterpènes",
"description": "Comment éviter l'exposition aux monoterpènes ?\nY a-t-il des recommandations pour l'utilisation des monoterpènes ?\nLes monoterpènes sont-ils sûrs pour les enfants ?\nComment stocker les produits contenant des monoterpènes ?\nLes monoterpènes peuvent-ils interagir avec des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D039821?mesh_terms=Cognitive+Dysfunction&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Monoterpènes",
"description": "Comment les monoterpènes sont-ils utilisés en médecine ?\nLes monoterpènes sont-ils efficaces contre les infections ?\nPeut-on utiliser les monoterpènes en aromathérapie ?\nY a-t-il des contre-indications pour les monoterpènes ?\nComment les monoterpènes sont-ils administrés ?",
"url": "https://questionsmedicales.fr/mesh/D039821?mesh_terms=Cognitive+Dysfunction&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Monoterpènes",
"description": "Quelles complications peuvent survenir avec les monoterpènes ?\nLes monoterpènes peuvent-ils causer des problèmes respiratoires ?\nY a-t-il des effets à long terme des monoterpènes ?\nLes monoterpènes peuvent-ils affecter la peau ?\nQuels sont les risques d'overdose de monoterpènes ?",
"url": "https://questionsmedicales.fr/mesh/D039821?mesh_terms=Cognitive+Dysfunction&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Monoterpènes",
"description": "Qui est à risque d'allergies aux monoterpènes ?\nLes travailleurs exposés aux monoterpènes sont-ils à risque ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes personnes atteintes de maladies respiratoires sont-elles à risque ?\nLes femmes enceintes doivent-elles se méfier des monoterpènes ?",
"url": "https://questionsmedicales.fr/mesh/D039821?mesh_terms=Cognitive+Dysfunction&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les monoterpènes dans un échantillon ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par chromatographie en phase gazeuse et spectrométrie de masse."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les monoterpènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de chromatographie et des analyses spectroscopiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les monoterpènes peuvent-ils être détectés dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être détectés dans le sang après ingestion ou exposition."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux monoterpènes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des irritations cutanées ou respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs pour les monoterpènes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour les monoterpènes."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des monoterpènes sur la santé ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des effets bénéfiques comme l'antioxydation ou des effets indésirables."
}
},
{
"@type": "Question",
"name": "Les monoterpènes causent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des allergies aux monoterpènes."
}
},
{
"@type": "Question",
"name": "Quels symptômes respiratoires peuvent survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, l'irritation de la gorge ou des difficultés respiratoires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les monoterpènes affectent-ils le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains monoterpènes peuvent avoir des effets neuroprotecteurs ou neurotoxiques."
}
},
{
"@type": "Question",
"name": "Peuvent-ils provoquer des maux de tête ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inhalation de certains monoterpènes peut déclencher des maux de tête chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Comment éviter l'exposition aux monoterpènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les produits contenant des huiles essentielles riches en monoterpènes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour l'utilisation des monoterpènes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez-les avec précaution et suivez les recommandations des professionnels de santé."
}
},
{
"@type": "Question",
"name": "Les monoterpènes sont-ils sûrs pour les enfants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains monoterpènes peuvent être irritants pour les enfants, il faut donc faire attention."
}
},
{
"@type": "Question",
"name": "Comment stocker les produits contenant des monoterpènes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conservez-les dans un endroit frais et sombre, à l'abri de la lumière et de l'humidité."
}
},
{
"@type": "Question",
"name": "Les monoterpènes peuvent-ils interagir avec des médicaments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains monoterpènes peuvent interagir avec des médicaments, consultez un médecin."
}
},
{
"@type": "Question",
"name": "Comment les monoterpènes sont-ils utilisés en médecine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour leurs propriétés anti-inflammatoires et antimicrobiennes."
}
},
{
"@type": "Question",
"name": "Les monoterpènes sont-ils efficaces contre les infections ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains monoterpènes montrent une activité antimicrobienne contre divers pathogènes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser les monoterpènes en aromathérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont largement utilisés en aromathérapie pour leurs effets relaxants et thérapeutiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des contre-indications pour les monoterpènes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes, comme les femmes enceintes, doivent éviter certains monoterpènes."
}
},
{
"@type": "Question",
"name": "Comment les monoterpènes sont-ils administrés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par inhalation, application topique ou ingestion."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les monoterpènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des irritations cutanées ou des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les monoterpènes peuvent-ils causer des problèmes respiratoires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition excessive peut entraîner des problèmes respiratoires chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des monoterpènes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études sont nécessaires pour évaluer les effets à long terme sur la santé humaine."
}
},
{
"@type": "Question",
"name": "Les monoterpènes peuvent-ils affecter la peau ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des irritations ou des sensibilisations cutanées chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'overdose de monoterpènes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une overdose peut entraîner des nausées, des vomissements et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergies aux monoterpènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies ou d'asthme sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les travailleurs exposés aux monoterpènes sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs dans l'industrie des parfums ou des huiles essentielles sont à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets des monoterpènes."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de maladies respiratoires sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être plus susceptibles de développer des complications respiratoires."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se méfier des monoterpènes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines huiles essentielles contenant des monoterpènes peuvent être déconseillées."
}
}
]
}
]
}
Cognitive dysfunction is part of the broad spectrum of clinical manifestations in older untreated hereditary transthyretin amyloidosis patients with peripheral polyneuropathy....
The objective of this study is to systematically explore cognitive dysfunction in ATTRV30M amyloidosis patients whose disease course was modified by liver transplant (LT)....
A series of 269 carriers of TTRVal30Met mutation treated with LT underwent a neuropsychological assessment. Clinical charts were reviewed to identify focal neurological episodes (FNEs), cognitive comp...
Cognitive dysfunction was identified in 35 patients (13%)-14 (5%) had mild and 21 (8%) had moderate dysfunction. In comparison to normal cognition, both mild and moderate cognitive dysfunction patient...
Consistent with the natural history of the disease, older age and higher severity of the disease are significantly associated and potentially predictors of cognitive dysfunction in ATTRV30M patients t...
The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas...
A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ...
Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an...
Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...
Stroke survivors not only suffer from severe motor, speech and neurocognitive deficits, but in many cases also from a "lack of pleasure" and a reduced motivational level. Especially apathy and anhedon...
(a) To characterize the frequency of objective cognitive deficits and self-perceived cognitive difficulties and (b) to explore demographic and clinical predictors of cognitive dysfunction and cognitiv...
One hundred and ten adults diagnosed with COVID-19 between March and November 2020, aged ≤ 74 years underwent a brief neuropsychological evaluation 12 months after infection, which included: Brief Vis...
Twenty participants (18.2%) had cognitive dysfunction and 36 (33.3%) had cognitive complaints. Cognitive dysfunction was related to lower education, preinfection history of headache/migraine, and acut...
A subset of individuals develops cognitive difficulties in the context of post-COVID syndrome. Results may support the protective effect of education, a known proxy of cognitive reserve. COVID-19 infe...
During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinica...
We performed a systematic review using PRISMA (Preferred Reported Items for Systematic Reviews and Meta-analysis) protocol. A systematic search was conducted in the PubMed/MEDLINE, EMBASE, LILACS, Sco...
Five original studies were included, which provided data from 428 participants. Among plasma proteins, SHH was increased and TTR was reduced in patients with mild cognitive impairment; anti-myelin bas...
Despite the relative scarcity of studies on this subject and the heterogeneity of results, we identified possible biomarkers for cognitive deficits in the RA population. Further longitudinal studies a...
Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) with a well-documented role in the innate and adaptive immune responses. Interestingly, TLR activation has also been linked to sever...
The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis....
To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients....
Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor...
A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in...
A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...
There is increasing recognition of the prevalence and impact of cognitive dysfunction (CD) in heart failure (HF) patients. This contemporary review appraises the evidence for epidemiological associati...
CD disproportionately affects heart failure patients, even accounting for known comorbid risk factors, and this may extend to subclinical left ventricular dysfunction. Neuroimaging studies now provide...
Cognitive dysfunction is increasingly recognized as a complication and comorbidity of diabetes, supported by evidence of abnormal brain structure and function. Although few mechanistic metabolic studi...
There is limited data on cognition in patients undergoing peritoneal dialysis (PD). We assessed prevalence and associated risk factors of neurocognitive impairment (NCI) in PD patients....
A cross-sectional cohort study of 149 PD patients at a single centre between 2016 and 2020 who underwent neurocognitive screening at defined intervals by Addenbrooke's Cognitive Examination - Revised ...
Patients on PD performed poorly in ACE-R screening compared to population norms, with discrepancy in all cognitive domains. In patients without CVD, attention and language domains were comparable to n...
Patients on PD have higher prevalence of NCI than the general population, primarily with impairments in memory, fluency and visuospatial reasoning. CVD confers poorer performance in attention and lang...